Inici › Melanoma › Texas › San Antonio
Assaigs clínics de Melanoma a San Antonio, TX
15 estudis de Melanoma busquen participants en centres de San Antonio i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Audie L Murphy VA Hospital, San Antonio
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
ReclutantFase 1/2
- START South Texas Accelerated Research Therapeutics, San Antonio
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
ReclutantEstudi observacional
- The University of Texas Health Science Center at San Antonio, San Antonio
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
ReclutantFase 1/2
- South Texas Accelerated Research Therapeutics (START), LLC, San Antonio
Project: Every Child for Younger Patients With Cancer
ReclutantEstudi observacional
- Children's Hospital of San Antonio, San Antonio
- Methodist Children's Hospital of South Texas, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
ReclutantFase 1/2
- Research Site, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
ReclutantFase 1/2
- UT Health Mays Cancer Center, San Antonio
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
ReclutantFase 1
- START San Antonio, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
ReclutantFase 1/2
- Clinical Trial Site, San Antonio
IDOV-Immune for Advanced Solid Tumors
ReclutantFase 1
- South Texas Accelerated Research Therapeutics, San Antonio
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
ReclutantFase 1/2
- Next Oncology, San Antonio
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
ReclutantFase 1/2
- Next Oncology, San Antonio
- The Start Center for Cancer Care, San Antonio
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
ReclutantFase 1/2
- Research Site, San Antonio
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
ReclutantFase 1/2
- NEXT Oncology, San Antonio
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Reclutant
- University of Texas Health Science Center at San Antonio, San Antonio
Assaigs de Melanoma en altres ciutats
- Houston, TX59 estudis
- New York City, NY38 estudis
- Los Angeles, CA34 estudis
- Nashville, TN33 estudis
- Pittsburgh, PA31 estudis
- Boston, MA26 estudis
- Philadelphia, PA23 estudis
- San Francisco, CA22 estudis
- Durham, NC21 estudis
- Atlanta, GA21 estudis
- St. Louis, MO21 estudis
- Salt Lake City, UT21 estudis
Altres estudis a San Antonio
- Càncer de pulmó de cèl·lules no petites59 estudis
- Càncer colorrectal46 estudis
- Càncer de mama46 estudis
- Càncer metastàtic44 estudis
- Càncer (tots els tipus)41 estudis
- Obesitat40 estudis
- Diabetis tipus 237 estudis
- Sobrepès34 estudis
- Càncer d'ovari31 estudis
- Càncer de pàncrees31 estudis
- Càncer de pròstata28 estudis
- Càncer d'endometri27 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.